Work

Bintrafusp alfa (M7824) and eribulin mesylate in treating patients with metastatic triple negative breast cancer (TNBC)(NCT03579472)

Year: 2019

Type: article

Source: Annals of Oncology

DOI: 10.1093/annonc/mdz242.078

Authors: J.K. Litton, S. Damodaran, I.I. Wistuba, F. Yang, A. Contreras, A. Tam, L. Ojalvo, I. Dussault, C. Helwig, S. Moulder

Institutions: The University of Texas MD Anderson Cancer Center, Hospital Universitari Arnau de Vilanova, Hospital Universitario Ramón y Cajal, Complejo Hospitalario de Jaén, Merck Healthcare KGaA, Darmstadt (Germany), Hospital Universitario Virgen del Rocío, Onkologikoa

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2977316607

FWCI:

Cites:

Cited by:

Related to: 10